Kang Yuan Pharmaceutical: Approval Notification for Clinical Trial of Plantain Seed Tablets

Kangyuan Pharmaceutical announced that they recently received the Drug Clinical Trial Approval Notice for Plantago asiatica from the National Medical Products Administration. The main therapeutic functions of Plantago asiatica tablets are to promote diuresis, eliminate dampness, clear heat and turbidity, and are used for the treatment of damp-heat syndrome in diabetic kidney disease.